|
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITINGN/ASponsored by Memorial Sloan Kettering Cancer Center
Actively Recruiting
PhaseN/A
SponsorMemorial Sloan Kettering Cancer Center
Started2023-09-20
Est. completion2026-09
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations7 sites
View on ClinicalTrials.gov →
NCT06055894
Summary
The researchers are going this to look at how butyrate levels change in participants' stool after they are on a plant-based diet or dietary supplements (omega-3, curcumin or probiotics) for 2 weeks. All participants will have smoldering multiple myeloma (SMM) or monoclonal gammopathy of undetermined significance (MGUS). The researchers will compare how the different dietary changes affect butyrate levels in participants' stool.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Confirmed prior diagnosis MGUS or of smoldering myeloma (any time prior). However, confirmation of diagnosis must be documented in their last local oncologist clinic note within 6 months prior to study enrollment. * Age ≥18 years * Willingness to comply with all study-related procedures * Physically able to complete requirements for the study or has someone to assist with the requirements (such as meal preparation, stool shipment and survey completion) * Interested in learning to cook plant-based recipes * Access to smart mobile phone or device with camera and ability to download Keenoa app * Be residing within the United States for the study duration. * English speaking or a family member or caregiver who speaks English and is able to assist with the surveys and phone based Keenoa app. Exclusion Criteria: * Taking any supplements other than vitamin D, iron, vitamin B12, potassium, magnesium, calcium or those needed for a medical indication must be reviewed by PI. If patient is on a supplement (including curcumin, probiotic, omega3) they must stop these for 2 weeks prior to enrollment on study. * Patients that already follow a whole foods plant based diet (ovo-lactovegetarian or processed junk food vegan diets are not excluded). This will be per research dietitian evaluation and discretion after nutrition screening. * Legume allergy * Severe allergies such as anaphylactic shock to peanuts and/or tree nuts, such as cashews * Concurrent participation in weight loss/dietary trials or defined programs (that require specified diets/supplements on the program). Patients on weight loss drugs are eligible. * Mental impairment leading to inability to cooperate * Enrollment onto any other therapeutic investigational study * Concurrent pregnancy * Patients on full dose anticoagulation * If in the opinion of the investigator there maybe any concerns regarding the ability of the patient to complete the study safely * Current self-reported heavy alcohol use and is defined as \>5 drinks per day or \>15 drinks per week * Current self-reported illicit drug use (except inhaled marijuana, vaping or cigarette smoking or medical marijuana. * Has a condition requiring antibiotics within 14 days of study intervention administration. * Plan for travel during the study that would preclude adherence to prescribed diets * History of active inflammatory bowel disease or major gastrointestinal surgery (not including appendectomy or cholecystectomy) within 3 months of enrollment or any history of total colectomy, or bariatric surgery (bariatric surgery which does not disrupt the gastrointestinal lumen, i.e. restrictive procedures such as banding, are permitted)
Conditions4
CancerMonoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaMultiple Myeloma, Smoldering
Locations7 sites
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey, 07920
Urvi A Shah, MD, MS646-608-3713
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey, 07748
Urvi A Shah, MD, MS646-608-3713
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey, 07645
Urvi A Shah, MD, MS646-608-3713
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
Commack, New York, 11725
Thomas Kaley, MD212-639-5122
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York, 10604
Urvi A Shah, MD, MS646-608-3713
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorMemorial Sloan Kettering Cancer Center
Started2023-09-20
Est. completion2026-09
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations7 sites
View on ClinicalTrials.gov →
NCT06055894